Table 1.
Characteristics of people with PSC at the time of inclusion.
| Characteristic | Value, n (%) |
|---|---|
| Male sex | 52 (67.5) 0 (0%) |
| Age at inclusion, years | 35 (25–49) 0 (0%) |
| Type of PSC | |
| Intrahepatic only | 24 (31.2) |
| Intrahepatic and extrahepatic | 53 (68.8) 0 (0%) |
| IBD | 58 (75.3) |
| Ulcerative colitis | 31 (53.4) |
| Crohn disease | 23 (39.7) |
| Indeterminate | 4 (6.9) 0 (0%) |
| Total bilirubin (μmol/L) | 15.0 (10.9–20.0) 0 (0%) |
| AST (×ULN) | 1.1 (0.7–2.2) 2 (2.7%) |
| ALP (×ULN) | 1.4 (0.7–2.7) 2 (2.7%) |
| GGT (×ULN) | 2.3 (0.7–6.6) 2 (2.7%) |
| Serum albumin (g/L) | 41.5(38.2–44.2) 6 (8.5%) |
| PLT (×109/L) | 275 (209–339) 2 (2.6%) |
| Liver stiffness (kPa) | 9.5 (6.7–12.2) 0 (0%) |
| ANALI score without gadolinium | |
| 0 | 17 (22.1) |
| 1 | 12 (15.6) |
| 2 | 6 (7.8) |
| 3 | 14 (18.2) |
| 4 | 17 (22.1) |
| 5 | 11 (14.3) 0 (0%) |
| ANALI score with gadolinium | |
| 0 | 22 (34.4) |
| 1 | 5 (7.8) |
| 2 | 37 (57.8) 13 (17%) |
Quantitative variables are expressed as medians (IQR). Nominal variables are expressed as absolute number (percentage). Italic indicates missing data within the cohort and are expressed as absolute number (percentage).
ALP, alkaline phosphatase; AST, aspartate aminotransferase; GGT, gamma-glutamyl transpeptidase; IBD, inflammatory bowel disease; PLT, platelet count; PSC, primary sclerosing cholangitis; ULN, upper limit of normal.